The purpose of this study is to quantitatively assess the changes in liver fat content in cancer patients before and after treatment.
The main questions it aims to answer are:How does the liver fat fraction change before and after chemotherapy? In this study, patients undergoing mDixon Quant scanning are subjected to fully automated segmentation and measurement of liver fat content using artificial intelligence.
CT/B ultrasound showed no fatty liver
No MRI contraindications, including pacemaker, stent, metal implant, or claustrophobia
Received neoadjuvant/adjuvant chemotherapy
Missing follow-up information
Liver lesions (metastases, hemangioma, etc.)
Poor image quality